Geneos Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $496K | Buy |
|
|||||
|
2025
Q2 | $410K | Sell |
|
|||||
|
2025
Q1 | $968K | Buy |
|
|||||
|
2024
Q4 | $492K | Buy |
|
|||||
|
2024
Q3 | $722K | Sell |
|
|||||
|
2024
Q2 | $847K | Sell |
|
|||||
|
2024
Q1 | $814K | Sell |
|
|||||
|
2023
Q4 | $759K | Sell |
|
|||||
|
2023
Q3 | $746K | Sell |
|
|||||
|
2023
Q2 | $724K | Sell |
|
|||||
|
2023
Q1 | $852K | Sell |
|
|||||
|
2022
Q4 | $784K | Sell |
|
|||||
|
2022
Q3 | $773K | Buy |
|
|||||
|
2022
Q2 | $663K | Sell |
|
|||||
|
2022
Q1 | $822K | Sell |
|
|||||
|
2021
Q4 | $762K | Sell |
|
|||||
|
2021
Q3 | $702K | Sell |
|
|||||
|
2021
Q2 | $829K | Sell |
|
|||||
|
2021
Q1 | $750K | Sell |
|
|||||
|
2020
Q4 | $767K | Buy |
|
|||||
|
2020
Q3 | $198K | Buy |
|
|||||
|
2020
Q2 | $208K | Sell |
|
|||||
|
2020
Q1 | $245K | Buy |
|
|||||
|
2019
Q4 | $193K | Hold |
|
|||||
|
2019
Q3 | $141K | Hold |
|
|||||
|
2019
Q2 | $161K | Hold |
|
|||||
|
2019
Q1 | $212K | Buy |
|
|||||
|
2018
Q4 | $184K | Sell |
|
|||||
|
2018
Q3 | $222K | Hold |
|
|||||
|
2018
Q2 | $189K | Sell |
|
|||||
|
2018
Q1 | $195K | Hold |
|
|||||
|
2017
Q4 | $213K | Hold |
|
|||||
|
2017
Q3 | $253K | Sell |
|
|||||
|
2017
Q2 | $278K | Sell |
|
|||||
|
2017
Q1 | $223K | Sell |
|
|||||
|
2016
Q4 | $216K | Hold |
|
|||||
|
2016
Q3 | $236K | Buy |
|
|||||
|
2016
Q2 | $207K | Hold |
|
|||||
|
2016
Q1 | $234K | Buy |
|